APKN Airprotek International Inc. Corp.

Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects

Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects

Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is registered under the name of RAFARMA (THAILAND) CO., LTD. The Company intends to use the business entity for entering into new association agreements with Thai universities. New association agreements are currently under negotiations and are expected to cover research and joint projects in production of cannabis based products. Also, in the light of recent agreement with R. & D. BIOCOGENCY LABORATORIES GROUP, the Company will use the new entity to conduct clinical trials and license its new products in Thailand for future distribution in South-East Asian markets.

For more information, contact:

RAFARMA

(307) 429-2029

EN
25/08/2020

Underlying

APKNAirprotek International Inc. Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Airprotek International Inc. Corp.

 PRESS RELEASE
Free
APKN Airprotek Inter...

Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceuti...

Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences (Pvt) Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023. It is Sri Lanka's first and only pharmaceutical manufacturing facility for sterile liquid injections and infusions. The headquarters of the company is based in Kandy...

December 11, 2023 1 EN
 PRESS RELEASE
Free
APKN Airprotek Inter...

Rafarma Pharmaceutical news update

Rafarma Pharmaceutical news update Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet procedures required to comply with GAAP auditing standards. Due to the changed geopolitical situation, the company was unable to complete the review of some of the assets that were set for audit consolidation, namely Kraspharma and Bebig. The Company will continue to provide its shareholders with regular unaudited financial statements of Kraspharma and Bebig. Onc...

November 30, 2023 1 EN
 PRESS RELEASE
Free
APKN Airprotek Inter...

Rafarma Pharmaceuticals strengthens its position in Central Asia

Rafarma Pharmaceuticals strengthens its position in Central Asia Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development in the territory of the innovative research and production pharmaceutical cluster "Tashkent Pharma Park". Rafarma Pharmaceuticals is not new to the Central Asian market, the company has been operating there for a long time and plans to increase its presence by creating local production. Over the next three years, the company plans to bui...

April 29, 2022 1 EN
 PRESS RELEASE
Free
APKN Airprotek Inter...

Rafarma’s Slavich Noya Technology Division Expands Printing Production

Rafarma’s Slavich Noya Technology Division Expands Printing Production Nicosia, Cyprus, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) Slavich Noya Technology, part of the Rafarma Pharmaceuticals group of companies, is expanding its production capabilities as it is in active negotiations for the acquisition of two machines from BOBST (), one of the world’s leading suppliers of substrate processing, printing and converting equipment and services for the label, flexible packaging, folding carton and corrugated board industries. Slavich Noya Technology will great...

February 7, 2022 1 EN
 PRESS RELEASE
Free
APKN Airprotek Inter...

RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear...

RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international intergovernmental scientific organization established by eleven founding countries in 1956 and registered by the United Nations. The purpose of the current negotiations is the development and implementation of Rafarma Pharmaceuticals’ projects related to nuclear medicine technologies, radiopharmaceuticals, radiotherapy and pr...

December 21, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch